Altria Group, Inc.(MO)

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Latest News & Analysis
On! Plus Launch Offers Proof-of-Concept for Altria's Oral Transformation
On! Plus launch and FDA pilot inclusion signal Altria's shift from defensive margin management to product innovation and execution testing.
Altria's Earnings Beat Masks a Troubling Inflection on Volume
Q3 results reveal margin resilience undone by accelerating volume declines, forcing a defensive pivot toward buyback expansion.
Altria's Smoke-Free Pivot: Cost Discipline Fuels Next-Generation Growth
Altria's Optimize & Accelerate redirects cost savings to smoke-free growth with early execution metrics validating competitive commitment.
Altria's Smoke-Free Transition and Dividend Strategy
Altria navigates smoke-free transition and dividend strategy amid regulatory shifts. Key developments, financial performance, and market impacts analyzed.
Altria Group, Inc.: Financial Excellence | Latest Industry News
Comprehensive intraday analysis of Altria Group, Inc.'s (MO) latest developments, market trends, and strategic initiatives as of February 20, 2025.
Altria's Smoke-Free Revolution: Can Dividends and Innovation Coexist?
A comprehensive analysis of Altria Group's smoke-free transition, dividend strategy, and competitive market positioning.
Altria's Future: Smoke-Free Products, Dividends, and Regulatory Hurdles
Altria navigates smoke-free transition, dividend sustainability, and regulatory hurdles amid shifting market dynamics and growing competition. NJOY and on! are key to the future.
Altria (MO): Navigating the Smoke-Free Future, Regulatory Hurdles, and Dividend Sustainability
Altria (MO) navigates a smoke-free future, regulatory hurdles, and dividend sustainability. Strategic shifts and market dynamics shape its path forward.
Altria's Dividend, Smoke-Free Strategy, and Regulatory Challenges
Altria's dividend, smoke-free strategy, and regulatory challenges are under scrutiny. The company's financial strength and market dynamics are comprehensively analyzed.
Altria Group: Share Repurchase, Dividend, and Smoke-Free Strategy Analysis
Altria Group navigates a shifting market with share repurchases, dividend strategies, and smoke-free initiatives, facing regulatory and competitive challenges. Actionable insights provided.
Altria's ($MO) Transformation: Smoke-Free Future and Dividends
Altria navigates smoke-free transition, cannabis potential, and dividend sustainability amidst illegal e-vapor challenges. A comprehensive analysis of $MO's future prospects.
Altria (MO) Stock: Dividend Yield, Smoke-Free Transition
Altria (MO) demonstrates resilience as a safe-haven investment, balancing high dividends with smoke-free transitions amidst regulatory scrutiny and market shifts.
Altria (MO): Dividends, RRPs, and Regulatory Challenges
Analysis of Altria Group (MO): dividend appeal, reduced-risk product competition, regulatory pressures, and interest rate sensitivity shape investment decisions.
Altria (MO) in 2025: Navigating Regulatory Risks and Market Uncertainty
Altria (MO) faces regulatory hurdles with NJOY ACE, impacting dividend sustainability. Tariffs pose limited direct threat. Stock offers safe haven during market downturns.
Altria Group (MO) Analysis: Dividend Stability Meets Regulatory Headwinds
An in-depth look at Altria Group's position in late May 2025, analyzing its dividend strategy, regulatory challenges, strategic pivot to reduced-risk products, and valuation.
Altria Group (MO): Strategic Pivot, Regulatory Hurdles, and Dividend Stability
Altria Group navigates regulatory hurdles and illicit market growth while its smoke-free strategy and robust dividend yield remain central.
Altria Group's Strategic Pivot: Navigating Smoke-Free Growth
Altria Group's stock surged, reflecting investor confidence in its strategic pivot towards smoke-free products amid declining traditional cigarette volumes.
Altria Group (MO): High Dividend Yield Amidst Strategic Transformation
Altria Group ([MO](/dashboard/companies/MO)) maintains its high dividend yield amidst strategic shifts and regulatory challenges, bolstered by a recent S&P credit rating upgrade.
Altria's Smoke-Free Strategy: NJOY Setbacks, 'on!' Growth & Dividend Resilience
Altria's smoke-free transition faces a stark contrast: 'on!' nicotine pouches surge while NJOY e-cigarettes hit an $873M impairment. We analyze the financial impact and dividend sustainability.
Altria Group, Inc. Latest Analysis: Smoke-Free Transition, Dividend Sustainability, and Market Position
Altria Group's strategic pivot to smoke-free products, UBS upgrade, and dividend outlook reveal a resilient financial position amid industry challenges.
Altria Group Inc. (MO) Market Update: Dividend Safety Amid Strategic Smoke-Free Shift
Altria's strong free cash flow and manageable payout ratio support its dividend amid a strategic pivot to smoke-free products, despite volume declines and regulatory risks.
Altria Group, Inc. Market Update: Dividend Resilience & Strategic Growth Amid Industry Shifts
Explore Altria's strong dividend yield, pricing power of Marlboro, growth in 'on!' nicotine pouches, and robust financial health underpinning its 2025 market position.
Altria Group, Inc. Market Analysis: Pricing Strategy, Legal Risks, and Dividend Sustainability
A detailed analysis of Altria's pricing strategy amid volume declines, legal challenges, and the sustainability of its ~7% dividend yield backed by strong cash flow.
Altria Group FDA Juul Approval Impact & Reduced-Risk Product Strategy Analysis
Altria's strategic pivot with FDA's Juul approval reshapes its reduced-risk product portfolio, intensifies competition with PMI, and influences investor outlook.
Altria Group Q2 2025 Analysis: Dividend Sustainability & Smoke-Free Growth Power MO
Altria's Q2 2025 results highlight strong dividend sustainability fueled by pricing power and 'on!' nicotine pouches amid cigarette volume declines.
Altria Group Q2 2025 Earnings: Strategic Shifts, Dividend Sustainability & Growth of 'on!' Brand
Analyze Altria's Q2 2025 earnings, NJOY ACE exit impact, dividend sustainability, and growth in 'on!' nicotine pouches amid tobacco industry challenges.
Altria Group (MO) Dividend Sustainability and Smoke-Free Growth Insights
Explore Altria's financial resilience, smoke-free product growth, and dividend sustainability amid industry shifts and regulatory challenges.
Altria Group (MO): Dividend Resilience Amid a Smoke‑Free Pivot
Altria posted **FY2024 net income of $11.26B (+38.55%)** while free cash flow covered dividends 1.26x — the pivot to smoke‑free pouches drives the narrative, but risks remain.
Altria (MO) Analysis: Earnings Beat, 'on!' Growth, Regulatory Risks
Altria Group navigates regulatory pressures and declining cigarette volumes with strategic focus on smoke-free products like 'on!' pouches and diversification into cannabis.
Altria (MO): Dividend Durability vs. Smoke‑Free Pivot
Altria reported FY2024 net income of $11.26B and $8.61B free cash flow; robust payouts meet smoke‑free investment amid meaningful leverage and negative equity.
Altria Group (MO): Cash Power vs. Smoke-Free Transition — Dividend Durability Under Pressure
Altria delivered **$11.26B net income** and **$8.61B FCF** in FY2024 while trading at **~6.16% yield**; dividend safety hinges on smoke-free scale, pricing and regulatory risk.
Altria Group (MO): Dividend Durability Under Strain — Cash Flow vs. Regulatory Risk
Altria reported **FY‑2024 net income of $11.26B** and **FCF of $8.61B**, but payout ratios near **~79%** and regulatory risks leave the 6%+ yield exposed.